336 related articles for article (PubMed ID: 2769953)
1. [Evaluation and quantification of complement-sensitive red cells in PNH and aplastic anemia-PNH syndrome].
Shichishima T; Terasawa T; Uchida T; Kariyone S
Rinsho Ketsueki; 1989 Mar; 30(3):297-302. PubMed ID: 2769953
[TBL] [Abstract][Full Text] [Related]
2. [Changing complement sensitivity and PNH red cell population during the clinical course in a case of PNH with hypoplastic bone marrow].
Shichishima T; Yoshida M; Terasawa T; Konno I; Mita M; Uchida T; Kariyone S
Rinsho Ketsueki; 1987 Apr; 28(4):564-9. PubMed ID: 3626048
[No Abstract] [Full Text] [Related]
3. [Paroxysmal nocturnal hemoglobinuria and aplastic anemia].
Thollot F; Bordigoni P; Olive D
Arch Fr Pediatr; 1984 Mar; 41(3):197-200. PubMed ID: 6742973
[TBL] [Abstract][Full Text] [Related]
4. Complement-dependent hematopoietic inhibitors in the sera of patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Takahashi M
Int J Cell Cloning; 1987 May; 5(3):242-54. PubMed ID: 3598246
[TBL] [Abstract][Full Text] [Related]
5. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
6. RBC transfusions in paroxysmal nocturnal hemoglobinuria.
Gockerman JP; Brouillard RP
Arch Intern Med; 1977 Apr; 137(4):536-8. PubMed ID: 849085
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH), with special reference to aplastic anemia-PNH syndrome].
Takahashi R
Nihon Rinsho; 1978 Jul; 36(7):2740-5. PubMed ID: 702866
[No Abstract] [Full Text] [Related]
8. The aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome.
Conrad ME; Barton JC
Am J Hematol; 1979; 7(1):61-7. PubMed ID: 507047
[TBL] [Abstract][Full Text] [Related]
9. The novel monoclonal antibody By114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia.
Tooze JA; Saso R; Marsh JC; Papadopoulos A; Pulford K; Gordon-Smith EC
Exp Hematol; 1995 Dec; 23(14):1484-91. PubMed ID: 8542935
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of paroxysmal nocturnal hemoglobinuria (PNH)].
Chrobák L; Dulícek P; Zák P
Vnitr Lek; 2001 Dec; 47(12):880-6. PubMed ID: 11826554
[TBL] [Abstract][Full Text] [Related]
11. [A case of aplastic anemia-PNH syndrome (author's transl)].
Mizuno H; Yamada H; Yamada K
Rinsho Ketsueki; 1973 Dec; 14(12):1171-81. PubMed ID: 4799957
[No Abstract] [Full Text] [Related]
12. Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria.
Moore JG; Humphries RK; Frank MM; Young N
Exp Hematol; 1986 Mar; 14(3):222-9. PubMed ID: 3512279
[TBL] [Abstract][Full Text] [Related]
13. Complement-sensitive red cells in aplastic anemia.
Ben-Bassat I; Brok-Simoni F; Ramot B
Blood; 1975 Sep; 46(3):357-61. PubMed ID: 1148393
[TBL] [Abstract][Full Text] [Related]
14. [Simultaneous assessment of the complement-sensitive cells of red cells and reticulocytes in paroxysmal nocturnal hemoglobinuria by complement lysis sensitivity test].
Shichishima T; Terasawa T; Matsuda M; Uchida T; Kariyone S
Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1318-24. PubMed ID: 3825451
[No Abstract] [Full Text] [Related]
15. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.
Rosse WF; Dacie JV
J Clin Invest; 1966 May; 45(5):736-48. PubMed ID: 5935361
[No Abstract] [Full Text] [Related]
16. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
17. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins.
Schrezenmeier H; Hertenstein B; Wagner B; Raghavachar A; Heimpel H
Exp Hematol; 1995 Jan; 23(1):81-7. PubMed ID: 7995374
[TBL] [Abstract][Full Text] [Related]
18. High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia--A possible role of high endogenous IL-2 in their suppression.
Nissen C; Tichelli A; Gratwohl A; Warthmann C; Moser Y; dalle Carbonare V; Sendelov S; Chklovskaia E; Jansen W; Wodnar-Filipowicz A; Sadallah S; Speck B
Acta Haematol; 1999; 101(4):165-72. PubMed ID: 10436296
[TBL] [Abstract][Full Text] [Related]
19. Apparent hemolysis following intravenous antithymocyte globulin treatment in a patient with marrow failure and a paroxysmal nocturnal hemoglobinuria clone.
Tran MH; Fadeyi E; Scheinberg P; Klein HG
Transfusion; 2006 Jul; 46(7):1244-7. PubMed ID: 16836574
[TBL] [Abstract][Full Text] [Related]
20. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis.
Rosse WF; Dacie JV
J Clin Invest; 1966 May; 45(5):749-57. PubMed ID: 4956901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
